Moexipril hydrochloride: Difference between revisions

Revision as of 15:42, 14 April 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2], Amr Marawan, M.D. [3]

Moexipril tablet is an angiontensin converting enzyme inhibitor drug that is FDA approved for the treatment of hypertension, heart failure, left ventricular dysfunction after myocardial infarction, diabetic nephropathy. Adverse reactions include hypotension, rash, hyperkalemia, disorder of taste, cough. hypotension, rash, hyperkalemia, disorder of taste, cough.

@@ Line 6: / Line 6: @@
 {{SB}} UNIVASC<sup>®</sup>
-==Overview==
-Moexipril hydrochloride is a potent orally active non-sulfhydryl angiotensin converting enzyme inhibitor (ACE) which is used for the treatment of [[hypertension]] and [[congestive heart failure]]. Moexipril can be administered alone or together with other antihypertensives or [[diuretics]]. It works by inhibiting the conversion of [[angiotensin I]] to [[angiotensin II]]. Moexipril is available from Schwarz'Pharma under the trade name Univasc.
 ==Category==